<DOC>
	<DOCNO>NCT00174915</DOCNO>
	<brief_summary>The purpose study compare febuxostat , allopurinol placebo , daily ( QD ) , subject gout .</brief_summary>
	<brief_title>Phase 3 , Febuxostat , Allopurinol Placebo-Controlled Study Gout Subjects .</brief_title>
	<detailed_description>A Phase 3 Study compare 80 mg , 120 mg 240 mg febuxostat , allopurinol ( 300 mg normal renal function 100 mg impair renal function ) placebo administer daily subject gout . Subjects receive treatment 28 week .</detailed_description>
	<mesh_term>Gout</mesh_term>
	<mesh_term>Febuxostat</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Hyperuricemia ( serum urate ≥8.0 mg/dL gout American Rheumatism Association Criteria Renal function define serum creatinine level &lt; 2.0 mg/dL creatinine clearance &gt; 20 milliliter per minute ( mL/min ) Cockroft Gault formula . History xanthinuria Intolerance allopurinol Presence renal calculus , Alcohol intake ≥ 14 drinks/week Clinically significant medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Uric Acid , gout , xanthine oxidase , febuxostat , tophus</keyword>
</DOC>